The market expansion is further driven by the rising demand for innovative treatments addressing unmet medical needs in retinal care. As the understanding of retinal pathologies deepens ... emerging ...

There is a potential link between Alzheimer's disease and the herpes simplex virus-1 (HSV-1), which is a common cause for ...

Regeneron has scooped up Oxular, a retinal-disease-focused company based in the U.K., closing the deal at the very end of 2024. Word of the acquisition was first shared by Oxular’s former CEO ...

Sigma-2 receptor modulation using exogenous ligands reduces cellular damage associated with central nervous system degeneration in age-related pathologies such as Alzheimer’s disease, Parkinson’s ...

with greater amounts of viral proteins co-localized with tangles of phosphorylated tau -- one of the hallmarks of Alzheimer's disease pathology -- in brain regions especially vulnerable to ...

with greater amounts of viral proteins co-localized with tangles of phosphorylated tau—one of the hallmarks of Alzheimer's disease pathology—in brain regions especially vulnerable to Alzheimer ...

After years of stagnation in the search for a cure for Alzheimer’s — or at least breakthroughs — 2024 brought several exciting findings and confirmed others regarding the devastating dementing disease ...

Researchers have unveiled a critical mechanism that links cellular stress in the brain to the progression of Alzheimer's disease (AD ... cell type in Alzheimer's pathology.

A study from Washington University in St. Louis found taking suvorexant, a common insomnia medication, for two nights slightly decreased amyloid-beta and tau proteins linked to Alzheimer's.

The first pill to slow down the progression of Alzheimer’s disease is being studied for use on the NHS. Regulators are due to make a decision on the drug called hydromethylthionine mesylate ...